Access cutting-edge juvenile psoriatic arthritis treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access juvenile psoriatic arthritis specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related juvenile psoriatic arthritis treatment provided free
The purpose of this study is to evaluate the drug levels, efficacy, and safety of Deucravacitinib (BMS-986165) in pediatric participants with juvenile psoriatic arthritis.
Sponsor: Bristol-Myers Squibb
Check if you qualify for this juvenile psoriatic arthritis clinical trial in Chicago, IL
If you're searching for juvenile psoriatic arthritis treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced juvenile psoriatic arthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.